Low-dose tamoxifen halves recurrence of in situ breast cancer

The finding is practice-changing for women who are unable to tolerate the full dose, says researcher

Tamoxifen at a low dose reduces local and contralateral recurrence of breast intraepithelial neoplasia, according to a new randomised controlled trial.